Management of Digestive Haemorrhaging In CHRU of Brest During 2009 and 2014

Completed

• Conditions: Gastro Intestinal Bleeding

• Registration Number: NCT03379285
• Lead Sponsor: University Hospital, Brest

Brief Summary

Gastro intestinal (GI) bleeding is relatively frequent and may lead to intensive care unit admission. Although a restrictive strategy for red blood cell transfusion is supported by a large randomized controlled trial literature, less is known about the impact of transfusion strategy of other blood components and administration of anti fibrinolytic on clinical outcomes.

This study aims to identify parameters that may be associated with the risk of further bleeding in patients admitted to ICU for GI bleeding.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-03
• Primary Completion: 2016-12-31
• Study Completion: 2016-12-31
• Status Verified: 2017-10
• Study First Submitted: 2017-11-23
• Study First Submitted QC: 2017-12-15
• Last Update Submitted: 2017-12-15
• Study First Posted: 2017-12-20
• Last Update Posted: 2017-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 272

Inclusion Criteria

• Patients with Gastro Intestinal Bleeding admitted to either medical or surgical intensive care unit

Exclusion Criteria

• patients retrieved from another hospital
• age < 18 years consent withdrawal

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding	within a week	Bleeding persistance or recidive requiring an intervention or a scope

Secondary Outcome Measures

Name	Time	Method
mortality	during hospitalisation (28 days)	hospital mortality

Trial Locations

Locations (1)

CHRU de Brest; 🇫🇷 Brest, France